A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy
A phase 2 trial of Azacitidine and Cusatuzumab in acute myeloid leukaemia, run by OncoVerity, Inc., active and no longer recruiting.
Overview
A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy is a phase 2 interventional study registered as NCT04023526 by OncoVerity, Inc., with 103 participants enrolled, started 2019-07-29 and due to reach its primary completion in 2023-08-15. Interventions recorded: Azacitidine and Cusatuzumab. Results have been posted on the registry.
Similar pages
not linked directly; found by shared links- TrialA Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) Harboring IDH Mutations Who Are Not Candidates to Receive Intensive Induction Chemotherapy
Shares Azacitidine, Acute myeloid leukaemia and the tag pipeline.
- TrialA Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission
Shares Azacitidine, Acute myeloid leukaemia and the tag pipeline.
- TrialA Phase 2 Study of MAX-40279 Combined With Venetoclax and Azacitidine in Unfit Newly Diagnosed Acute Myeloid Leukemia
Shares Azacitidine, Acute myeloid leukaemia and the tag pipeline.
- TrialAn Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
Shares Azacitidine, Acute myeloid leukaemia and the tag pipeline.
- TrialA Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia
Shares Azacitidine, Acute myeloid leukaemia and the tag pipeline.
- TrialA Trial of AK117 (Anti-CD47 Antibody) in Patients With Acute Myeloid Leukemia
Shares Azacitidine, Acute myeloid leukaemia and the tag pipeline.
- TrialA Study of BGB-11417 in Participants With Myeloid Malignancies
Shares Azacitidine, Acute myeloid leukaemia and the tag pipeline.
- TreatmentBleximenib
Shares Johnson & Johnson, Acute myeloid leukaemia and the tag pipeline.